PhaseBio Pharmaceuticals has secured $34 million in Series D financing to advance the clinical development of PB1046, an investigational therapy…
Articles by Janet Stewart, MSc
A certain protein found on white blood cells, which plays a role in causing pulmonary arterial hypertension (PAH), may…
Actelion Pharmaceuticals submitted a supplemental new drug application to U.S. regulatory authorities seeking expanded approval for Opsumit (macitentan) to…
A compound in a plant that is used in traditional Chinese medicine lowered the lung blood pressure of rats with…
Plans for a Phase 2 clinical trial of levosimendan, a proposed treatment for pulmonary hypertension associated with heart failure and…
American researchers have identified three blood-flow measurements that could help doctors predict the outcomes of people whose pulmonary hypertension stems…
Many people with chronic kidney disease also have pulmonary hypertension, a condition that increases their risk of heart problems and…
The first healthy participants have been injected with CAM2043 (treprostinil FluidCrystal Injection Depot) in a Phase 1 study assessing the…
Patients with blood clots in the lungs known as chronic thromboembolic pulmonary hypertension (CTEPH) can benefit from…
PhaseBio Pharmaceuticals has secured $15.6 million in funds to develop its pipeline for orphan drugs led by PB1046, which…
Male gender and lung function parameters have been identified as risk factors for progression of pulmonary arterial hypertension in patients with systemic…
A heart chamber malfunction leads to worse survival in pulmonary arterial hypertension (PAH)Â patients who have had a double lung transplant,…